ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPTI Optibiotix Health Plc

18.125
0.00 (0.00%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.125 17.75 18.50 18.125 18.125 18.13 111,277 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.38 16.52M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18.13p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.52 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.38.

Optibiotix Health Share Discussion Threads

Showing 59376 to 59400 of 147650 messages
Chat Pages: Latest  2378  2377  2376  2375  2374  2373  2372  2371  2370  2369  2368  2367  Older
DateSubjectAuthorDiscuss
09/10/2019
08:25
The value largely hinges on Phase 3 results still and these are always very hard to predict. Today’s news is undoubtedly positive. But without knowing the Phase 3 outcome, any attempt at valuation remains a “finger in the air” job at this stage.
lord loads of lolly
09/10/2019
08:22
Hami / Buywell ...yaaaaaaaaaaWn. Still here? Wipe the slime trail when leaving please.The Fantasy Island, pork pie telling team returns.
whitegold1
09/10/2019
08:18
3p ... cant be right ... Goetz /SOH.s cunning plan Baldrick.
whitegold1
09/10/2019
08:17
GRAS

In evaluating the safety of the intended use, the FDA considers only safety;
benefits are not evaluated, although health claims may be considered by the FDA under a separate petition process.

buywell3
09/10/2019
08:16
Lets just remind everyone After 5 years of trying GBP40 million MCap OPTI produced just 147k revenue Burning Cash At the AGM Special Resolution was passed for another possible dilutive placing
hamidahamida
09/10/2019
08:14
I am amazed that Goetz think the Pharma LPLDL is only worth 3p. The milestones almost amount to that value. Should be much higher IMHO.
nobbygnome
09/10/2019
08:13
Marvellous James - lets hope our seller doesnt decide to take advantage of our good news and ruin our party and any rise. Fingers crossed. Slugs our tgere, blackbird incoming - run.
whitegold1
09/10/2019
08:13
Marvellous James - lets hope our seller doesnt decide to take advantage of our good news and ruin our party and any rise. Fingers crossed. Slugs our tgere, blackbird incoming - run.
whitegold1
09/10/2019
08:11
Definitely good news, though as the RNS references the Feb 19 announcement, I had mistakenly thought we had achieved this already.

If I am correct this could affect the Goetz valuation. In chart 119, LPldl (pharma) is rated high risk with only 10% probability of success. So this accreditation might bump that probability up a bit. At 10%, Goetz value LPldl (pharma) at 3p out of the total valuation of 97p.

Any thoughts on the Goetz note appreciated. MU

m4rtinu
09/10/2019
08:11
Although everyone is entitled to their views, I don't know why people like Sienna bother posting without backing the reasons for not investing in OPTI. Just invest somewhere else. There is still a way to go, but GRAS is a gold standard for many countries and will allow pharmas to get on board with Phase 3 trials. Good news imo, but it may take some time. I think eventually this will fly.
2vdm
09/10/2019
08:09
Isn’t it wonderful to see all the muppets desperately panicking over their short. I love it.
jamesrs1
09/10/2019
08:07
Cheers Nobby ...Phase 111 ...good.
whitegold1
09/10/2019
08:06
Google away Buywell. You have zero credibility. Stop trying to sound knowledgable - it it aint working - you.re not while blatantly trying to scare small pi.s you utter slimeball.Hope you.re short spreadbet is hurting today. What an infestation of trolls here.
whitegold1
09/10/2019
08:04
The important thing about GRAS is the safety so that the Pharma company can go straight to phase III and multiple companies can put the LPLDL in whatever food product they want with absolutely no concern. Massive!
nobbygnome
09/10/2019
08:03
I see buywell is frantically googling to find anything which possibly could be conceived as negative. Very sad....
nobbygnome
09/10/2019
08:00
GRAS

In evaluating the safety of the intended use, the FDA considers only safety;
benefits are not evaluated, although health claims may be considered by the FDA under a separate petition process.

buywell3
09/10/2019
08:00
Good news. What I.m not happy about, and it might be my fault, is that I was totally unaware of this manufacturing additional bit of paper. Is there are similar one reqd for the EU equivalent? These extra reqs clearly stop any potential revenue ( bar the milestone bit) I feel like a shroom - sadly. I.m a loyal holder, occasionally ignorant of wider matters but tiday I feel cheesed but pleased.
whitegold1
09/10/2019
07:58
Sienna i'd be surprised if purple knows what a probiotic is
webb93
Chat Pages: Latest  2378  2377  2376  2375  2374  2373  2372  2371  2370  2369  2368  2367  Older

Your Recent History

Delayed Upgrade Clock